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Abstract
Background: We retrospectively reported our 26-year experience with operative repair of total anomalous
pulmonary venous connection (TAPVC) with biventricular physiology.
Methods: Between December 1982 and December 2008, 122 TAPVC patients with biventricular heart underwent
surgical repair in our department. Moderate or deep hypothermia was induced at the time of cardiopulmonary
bypass (CPB). Follow-up was conducted for 5 postoperative years. Surgical outcomes of early and intermediate
deaths after TAPVC repair were retrospectively analyzed.
Results: Six deaths occurred operatively; and three deaths, during follow-up. The 5-year survival rates after TAPVC
repair was 92.6 %, without gradient across the anastomosis. The survival rate of the patients who were younger
was 78.8 %, significantly lower than those older than 1 year. It was also lower in those who were less than 6 kg in
weight. Three patients died during follow-up. Three patients died of ventricular arrhythmia, right heart failure, and
pneumonia, respectively, during follow-up. If the left atrium pressure was higher than 15 mm Hg, the snare of the
vertical vein was loosened after CPB ceased in the patients with supracardiac connection. It decreased from 21 ± 5
to 13 ± 3 mm Hg. The vertical vein was ligated in 57 cases and left open in 20 cases. A patient with an intact
vertical vein had a large shunt and was cured by intervention afterward. Supraventricular arrhythmia occurred in 19
patients with the supercardiac type repaired through a biatrial incision. One patient died of ventricular arrhythmia,
and none of the remaining patients had arrhythmias.
Conclusion: Surgical treatment of TAPVC carried a low operative risk and had satisfactory immediate and intermediate
results. Age younger than 1 year and weight less than 6 kg were risk factors. It was a good choice to leave the vertical
vein open in the patients with a left atrial pressure higher than 15 mm Hg.
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Background
Total anomalous pulmonary venous connection (TAPVC)
is a relatively uncommon anomaly in which connection
between the pulmonary veins and the left atrium is absent,
accounting for only about 1.5 % to 3 % of cases of con-
genital heart disease [1, 2]. The pulmonary veins establish
an anomalous connection that delivers pulmonary venous
blood to the right side of the heart rather than to the left
side. A patent foramen ovale or an atrial septal defect
provides a right-to-left shunt so that an admixture of
oxygenated and unoxygenated blood eventually reaches
the left side of the heart. Without the right-to-left
shunting of blood, an infant would die [3]. It is a life-
threatening congenital cardiac malformation that requires
surgical therapy. It can be categorized according to the
site of drainage into the systemic circulation (supracardiac,
45 %; infracardiac, 25 %; cardiac, 25 %; mixed, 5 %) [4].
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Surgical repair is best performed at the time of diagnosis,
as an elective procedure, to avoid potential long-term
problems associated with right heart volume and pres-
sure overload, or long-standing cyanosis. The surgical
correction of TAPVC has become increasingly success-
ful owing to early referral, improved surgical and
anesthetic techniques, and improved intraoperative and
postoperative care.
While surgical repair of TAPVC has historically been as-
sociated with a significant risk of early mortality, with re-
ports in the literature ranging from 10 % to 50 % [5, 6].
Many reports have argued that among patients with con-
genital heart defects, those with TAPVC and single-
ventricle physiology have the poorest survival [7–9]. These
patients undergo procedures including Fontan, bidirec-
tional Glenn, systemic-pulmonary shunt, or pulmonary
artery banding, obviously with high operative mortality
and poor long-term survival [4, 10]. Patients with biventri-
cular physiology had good results, but 1-month survival
was 90 % in a previous study [5] and 95.1 % at our center.
Earlier studies indicated that biventricular patients with
preoperative pulmonary venous obstruction were at a high
risk of post-repair pulmonary venous obstruction, which
this has been neutralized as a risk factor in some more-
recent studies [11]. We have performed operations for
TAPVC in our center since 1982. Patients with single-
ventricle physiology were fewer because of reasons such
as economic status and age. We argued it in single
ventricular operation. We obtained better results in
patients with biventricular physiology. However, whether
the vertical vein should be ligated at the time of total
anomalous pulmonary venous repair is controversial.
Herein, we report retrospectively our 26-year experience
with TAPVC and biventricular physiology, including
clinical presentations, operative techniques, results, and




Between December 1982 and December 2008, 122
patients with TAPVC and biventricular hearts underwent
surgical repair at Northern Hospital, Liaoning province,
China. We retrospectively evaluated these patients,
whose characteristics (54 males and 68 females) are
summarized in Table 1. The mean age of the patients at
operation was 8.5 ± 7.0 years (27 days to 44 years), with
18 patients younger than 1 year. The mean body weight
was 20.1 ± 14.6 kg (from 2.7 to 87 kg), with 12 patients
less than 6 kg in weight. Of the patients, 112 (91.8 %)
had symptoms of tachypnea, cyanosis, or failure to
thrive. They were diagnosed by using echocardiography,
cardiac catheterization and cineangiography, or com-
puter tomography. TAPVC was classified as supracardiac
in 77 patients (63.1 %), cardiac in 39 patients (32.0 %),
infracardiac in one patient, and mixed in 5 patients
(4.1 %). Twenty-one patients required preoperative ino-
tropic support, and 10 required mechanical ventilation.
Emergency surgery was performed in 8 patients, of
whom 7 were younger than 1 year and 6 were weighed
less than 6 kg. All of the patients who underwent
emergency surgery had severe dyspnea and continuous
metabolic acidosis before the operation. Associated
malformations included patent ductus in 21 patients,
pulmonary stenosis in 5 patients, and moderate or
severe tricuspid regurgitation in 28 patients. Twenty-five
patients had moderate pulmonary artery hypertension
(PAH) and 27 had severe PAH.
Surgical technique
All of the operations were performed under general
anesthesia through median sternotomy. Cardiopulmonary
bypass (CPB) was commenced with ascending aortic
perfusion and bicaval cannulations. Moderate or deep
hypothermia was induced. Measures to ensure myocardial
protection included cold blood cardioplegia infusion.
In the patients with supracardiac connection, biatrial
incision (n = 66) or the modified superior approach [12]
were used. In patients with supracardiac or infracardiac
connections, the snare of the vertical vein was loosened
if the left atrium pressure was higher than 15 mm Hg
after CPB ceased in the patients with supracardiac
Table 1 Patient characteristics





Age at operation, year 8.5 ± 7.0
Age≤ 1 year 18
Body weight
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connection. Left atrial pressures (LAPs) were recorded
before and after the snare was loosened. The vertical
vein was ligated in 57 patients and left open in 20
patients. In the patient with infracardiac connection
(n = 1), the apex of the heart was tilted up to the right
and then the vertical vein was ligated and incised to the
diaphragm. The common pulmonary venous chamber
was anastomosed to the back of the left atrium. Mean-
while, the associated malformations were handled at the
operation.
The patients were followed up in the outpatient de-
partment by clinical examination, echocardiography, and
electrocardiography for 5 years after repair.
Statistical analysis
Quantitative data were expressed as mean ± the standard
deviation values as appropriate. The end point of follow-
up was TAPVC repair until the date of death, lost to
follow-up, or 5 years after the operation. All P values
were two-sided, and a P < 0.05 was considered statisti-
cally significant. Age (younger than 1 year), sex, and type
(supracardiac or infracardiac, for cardiac and mixed
cases were few) were determined by using the chi-
square test. Quantitative data (weight, bypass time, and
clamp time) were analyzed by using a t test. LAPs before
and after the snare was loosened were analyzed by per-
forming a paired t test. Statistical analysis was performed
with the SPSS Version 13.0 software package (SPSS Inc,
Chicago, IL).
Results
Six early deaths (4.9 %) occurred. One patient with
supracardiac connection died intraoperatively from
failure to successfully wean from the CPB. The patient
was a 3-month-old infant. Owing to severe dyspnea and
continuous metabolic acidosis, mechanical ventilation
was applied preoperatively. Emergency surgery was per-
formed. During the time of bypass assistance, the heart
contracted weakly and oxygenation worsened. Despite
various attempts, the patient could not be weaned from
CPB. The reasons may be the poor preoperative status,
systemic inflammatory response syndrome, or poor
cardiac protection. Two patients with severe pulmonary
artery hypertension, whose pulmonary vascular resist-
ance values were 20 and 13.4 Wood units, respectively,
died from low cardiac output. One died of ventricular
fibrillation 15 days after the repair, and the other two
died of pulmonary infection and respiratory failure
30 days after the repair. One month after the repair, 116
patients survived.
Among the 18 patients younger than 1 year, four died.
However, among the remaining 104 patients, only two
died later. The results of the statistical analysis showed
that the patients younger than 1 year had a higher
mortality risk than the others (P = 0.000; Fig. 1a). No
statistically significant differences were observed among
the patients in terms of sex and type (supracardiac or
cardiac).
The survival rate was 75 % in the patients who
weighed less than 6 kg. In the t test, weighing less than
6 kg was also a risk factor (P = 0.001). The risk was
89.5 % in those weighing 6–10 kg (Fig. 1b). Among the
27 patients with severe PAH, 3 died. Their mortality was
significantly higher than that of the patients with moder-
ate PAH (1/25 patients). The mean duration of CPB was
95.3 ± 33.9 min (range, 35.0–227.0 min), and the mean
aortic cross-clamp time was 52.5 ± 22.2 min (range, 12–
123 min). Hospital death was not correlated with bypass
time (P = 0.441) or cross-clamp time (P = 0.772).
Emergency surgery was performed in 8 patients, of
whom 7 were younger than 1 year and 6 weighed less
than 6 kg. This is the reason why the mortality rate was
22.2 % in the younger patients and 25 % in the patients
who weighed less than 6 kg.
The actuarial 5-year survival rates after TAPVC repair
was 92.6 % (Fig. 2). Three patients died during follow-up
owing to ventricular arrhythmia, right heart failure, and
pneumonia at 5 months, 11 months, and 2 years after
repair, respectively. A boy with myelodysplastic syn-
drome with a platelet count of 30,000/mL was treated
with medicine. Seven patients were lost to follow-up.
The others remained in New York Heart Association
class I and II functional status, without medication.
Echocardiographic studies revealed no gradient across
the anastomosis in the patients.
The patients with the vertical vein ligated at operation
were all well except one boy whose pulmonary vascular
resistance was 7.3 Wood units and who often had chest
distress. When the LAP is higher than 15 mm Hg,
loosening the snare of the vertical vein can reduce the
LAP from 21 ± 5 mm Hg to 13 ± 3 mmHg (P < 0.05). In
the patients with the vertical vein left intact, the
shunt closed spontaneously in 8 and the shunt re-
mained in 12. Among the 12 patients, 11 had a small
left-to-right shunt and were monitored regularly. How-
ever, a 27-year-old female patient still had a large shunt,
and the Qp/Qs value was 3.2 at 6 months after repair. We
performed atrial septal defect closure by using of 34 mm
(Shape Memory Co., Ltd, Shanghai; Fig. 3). The shunt and
palpitation disappeared.
Supraventricular arrhythmia occurred in 19 patients
who underwent supercardiac TAPVC repair through a
biatrial incision, including atria extrasystole in 9 patients,
relay of cardiac rhythm in 7, and atrial fibrillation in 3.
The crista terminalis was incised, and the internodal
tract was damaged during the repair through a biatrial
incision. This may have contributed to the potential for
arrhythmias. All of the patients recovered to normal
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sinus rhythm during 1 week after the operation. A 7-
year-old girl died of ventricular arrhythmia 5 months
after the operation. In another patient, atrial flutter per-
sisted for 6 months after repair and subjected to electro-
version to sinus rhythm by shock. None of the patients
had arrhythmias.
Discussion
Total anomalous pulmonary venous connection is a rare
congenital malformation with an unfavorable natural
prognosis. Only 20 % of patients survive the first year of
life [13]. TAPVC in univentricular hearts included het-
erotaxy syndrome and pulmonary atresia, and such
procedures as Fontan procedure, bidirectional Glenn
procedure, systemic-pulmonary shunt, or pulmonary
artery banding could be performed. TAPVC is usually
associated with pulmonary venous obstruction and
worse outcomes. Thus, we include a discussion on
heterotaxy syndrome and pulmonary atresia.
For most patients with supracardiac TAPVC, we
choose biatrial incision for total repair, which was de-
scribed by Shumacker and King [14]. Another technique
for dealing with the supracardiac type is a modified
superior approach described by Serraf, especially for
some patients younger than 1 year. This approach can
be useful to enhance exposure during surgical repair and
may contribute to an improved patient outcome. We
used this approach successfully on patients with the
infracardiac drainage type treated by making an biatrial
incision. It can keep the heart in the normal position
while keeping the anastomosis of the orifice unob-
structed. While anastomosing the posterior orifice by
lifting the heart upward and in the anterior direction,
when the heart was returned, it was possible that anasto-
mosis became kinked and turned, so the pulmonary vein
drainage was blocked. It is interesting that only one
patient had an infracardiac TAPVC, which may be due
to the relatively older age of admission. This may be a
reflection of socioeconomic status and late or no referral
to the tertiary care center. This may explain why such a
relatively old patient population would present with
symptoms such as tachypnea, failure to thrive, and
cyanosis.
Whether the vertical vein should be ligated at the time
of total anomalous pulmonary venous repair is contro-
versial. We considered that it may be well to leave the
vertical vein open even though we obtained good results.
One reason may be that the age in this group is some-
what old, and the pulmonary veins were not seriously
obstructed. First, keeping the vertical vein open can
alleviate the right ventricular load in the patient with
serious pulmonary hypertension, and it can also alleviate
the left ventricular load in the patient with poor
ventricular compliance. Second, in infracardiac TAPVC,
keeping the vertical vein open can also prevent hepato-
necrosis. Last, the vertical vein can be closed by using
Fig. 1 Survival rate of patients with different age and body weight. a Survival rate of patients younger than one year is much lower than those
older; b Survival rate was 77.8 % in patients who were ≤6 kg in weight. It was much lower than that of patients who were 6 ~ 10 kg or >10 kg
in weight
Fig. 2 Five-year surival rates of TAPVC repair. At one month after
TAPVC repair the surival rate was 95.1 %; there was none dead from
two years to five years after operation. Actuarial 5-year survival
is 92.6 %
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the favored methods of adjustable means or intervention
when the pulmonary pressure descends satisfactorily or
the left ventricle is well trained. Chowdhury et al. pre-
ferred that an adjustable means can be used to close up
the vertical vein after operation [15]. In our study, a
woman aged 27 years was cured by intervention after-
ward. Kobayashi et al. also reported a similar case [16].
Although vertical vein ligation is recommended to close
shunting, small left heart chambers may not always
tolerate the immediate increase in blood flow [17].
Transcatheter vertical vein closure might render patients
with high LAP suitable candidates for further hybrid
approach.
In recent years, some centers reported that repair of
TAPVC carried a relatively high early mortality (10–
20 %) [2, 18]. However, in our department, only 6
deaths (4.9 %) occurred in the first month of repair. In
the West, most patients who underwent TAPVC repair
were neonates and young infants [11, 19, 20]. However,
in our department, the age of most patients (85.2 %)
who underwent TAPVC repair was older than 1 year.
These patients rarely had obstructed drainage and
moderate or severe pulmonary arterial hypertension.
Thus, these patients (>1 year of age) seem naturally
selected, representing 20 % of patients who survive
beyond the first year of life. These were the important
factors that might have contributed to such a low
mortality rate in our department. The survival rates of
patients with TAPVC and single-ventricle physiology
were among the worst of all patients with congenital
heart defects. Repeated operations for pulmonary
venous obstruction were predominantly required in pa-
tients who underwent operation as neonates [5, 21].
We achieved good results with low mortality and few
repeated operations, as the patients in this group were
those with TAPVC and biventricular physiology. Those
with pulmonary venous obstruction preoperation were
indicated for emergency surgery, and we did not find
post repair obstructions in pulmonary veins and an
increase in early mortality rate.
Our data show that age younger than 1 year and
weight less than 6 kg are risk factors, which may be due
to emergency surgery. Eight patients underwent emer-
gency surgery, of whom 7 were younger than 1 year and
6 weighed less than 6 kg. All of the patients who under-
went emergency surgery had severe dyspnea and con-
tinuous metabolic acidosis preoperatively. When weaned
from CPB, the patients usually had low blood pressure
and became later prone to develop complications such
as low cardiac output and infection with mechanical
ventilator. Severe PAH often results in low cardiac
output, arrhythmias, and lung complications. However,
if the patients survived the perioperative period, they
would have good results in the future.
Conclusions
In conclusion, most patients who undergo repair with
TAPVC can expect excellent outcomes with regard to
survival, freedom from reintervention, and overall func-
tional ability. However, the mortality rate is 22–25 % in
the patients younger than 1 year of age or less than 6 kg
in weight because of emergency surgery. If this path-
ology is not an emergency and the age and weight at
presentation are older than 1 year and at least 6 kg, then
one can obtain more-favorable results. However, the
study is a retrospective review of medical records in a
relatively small population. Its limitations also include
the lack of a randomized controlled trial.
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Fig. 3 A case using an atrial septal defect amplatzer to close vertical vein six months after TAPVC repair. The patient was initially operated on
with the vertical vein left open. Six months after the repair, the shunt was occluded with a atrial septal defect amplatzer by intervention. a Angiographic
image of not ligated vertical vein; b Angiographic image when an ASD amplatzer implanted; c: Radiography after the amplatzer released
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